We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Stay up to date on the topics that matter to you

Dr Nathan Moore profile page

Associate Director, Engineering & Automation Cell Therapies, Pharmaceutical Sciences Takeda

Got a Question for Dr Nathan Moore?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content

Total: 1

Webinar

Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing

Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the market.

Never miss a story

with the Breaking Science News daily newsletter